Company Filing History:
Years Active: 2010-2013
Title: The Innovations of Yu-Li Lin: A Focus on Docetaxel
Introduction: Yu-Li Lin is an accomplished inventor based in Yongkang, Taiwan, specializing in the field of pharmaceutical innovations. With two patents to his name, Lin has made significant contributions, particularly in the preparation and formulation of docetaxel, a widely used chemotherapy medication.
Latest Patents: Lin's work includes two notable patents regarding crystalline forms of docetaxel. His innovations detail a new anhydrous crystalline form of docetaxel and the processes for their preparation. The patents provide methods for creating both anhydrous docetaxel and docetaxel trihydrate, enhancing the efficiency and effectiveness of this important pharmaceutical compound.
Career Highlights: Lin's career includes significant positions at Scinopharm Singapore Pte Ltd., a company known for its pharmaceutical manufacturing and development. His experience in these roles has allowed him to refine his expertise in drug formulation and patent development, contributing to his success as an inventor.
Collaborations: Throughout his career, Lin has worked alongside talented colleagues, including Yuan-Xiu Liao and Meng-Fen Ho. These collaborations have fostered an environment of innovation and creativity, leading to the advancement of novel pharmaceutical solutions.
Conclusion: Yu-Li Lin’s contributions to the pharmaceutical industry emphasize the importance of innovation in drug development. His patents reflect significant advancements in the preparation of docetaxel, paving the way for improved therapeutic options in cancer treatment. Lin's work not only highlights his inventive spirit but also serves as an inspiration to aspiring inventors in the field.